Loading clinical trials...
Loading clinical trials...
Toward a Less Toxic Yet Highly Effective Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Children and Adolescents With Severe Sickle Cell Disease: A Pilot Study
Conditions
Interventions
fludarabine
Locations
10
United States
University of Alabama-Birmingham
Birmingham, Alabama, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
All Children's Research Institute Inc.
St. Petersburg, Florida, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Tulane University
New Orleans, Louisiana, United States
Wayne State University
Detroit, Michigan, United States
Start Date
February 1, 2009
Primary Completion Date
March 1, 2014
Completion Date
January 11, 2016
Last Updated
July 25, 2017
NCT05170412
NCT04276870
NCT06526117
NCT06665997
NCT07431398
NCT07222475
Lead Sponsor
Emory University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions